- Human clinical trials of a potential coronavirus vaccine are all set to begin.
- It is being developed by scientists at the University of Oxford.
- They believe that there is an 80 percent chance of success.
- A sum of £20million of public money has been provided for each of the vaccine development projects.
- Another institute trying to develop a vaccine for COVID-19 is the Imperial College London.
- They said that the super-fast vaccine will be available by September.
According to an article published in The Telegraph UK, human trials of a potential coronavirus vaccine is all set to begin.
Human clinical trials to start
In a press briefing on Tuesday, UK Health Minister Matt Hancock announced that the vaccine from the Oxford trial will be tested in people from this Thursday.
The vaccine is being developed by scientists at the University of Oxford who believe there is an 80 percent chance of success.
Matt Hancock also promised £20million of public money for each of the vaccine development projects. Another institute trying to develop a vaccine for COVID-19 is the Imperial College London.
A vaccine to be available by September
The Jenner Institute team at Oxford though is planning the production of the vaccine even before the trial is complete so that at least a million doses are ready by September.
UK Health Secretary Matt Hancock, during the daily press conference at 10 Downing Street, said the government will provide 20 million pounds to the Oxford research team to help fund their clinical trials, with a further 22.5 million pounds for researchers at Imperial College London.
“The best way to defeat coronavirus is through a vaccine after all this is a new disease, this is an uncertain science, but I am certain we will throw everything we’ve got at developing a vaccine,” Matt Hancock said.
The UK health minister said they are also investing in manufacturing capability, “so if either of these vaccines safely works, then we can make it available for the British people as soon as humanly possible.“
News confirmed by scientists at the University of Oxford
Scientists at the University of Oxford last week promised a super-fast vaccine during a virtual press conference, saying the vaccine will be available by September. According to lead researcher Professor Sarah Gilbert, their ‘ChAdOx1’ vaccine can work against the coronavirus called SARS-CoV-2.
In the normal course of time, a vaccine takes anytime between 12-18 months.
What probably separates ChAdOx1 – known as recombinant viral vector vaccine – from the rest is the time it promises to take in order to deliver mass quantities.
Researchers enrolled over 500 healthy volunteers to test if their vaccine can prevent the novel coronavirus.
The vaccine developed at Oxford’s Jenner Institute
The vaccine is an adenovirus vaccine vector and was developed at Oxford’s Jenner Institute. Adenoviral vectors are a very well-studied vaccine type, having been used safely in thousands of participants, from 1 week to 90 years of age, in vaccines targeting over 10 different diseases.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!